Thermo Fisher Scientific Inc (TMO NYSE) stock market data APIs
$575.0279
0.61(0.1%)
as of November 20, 2025
Try our APIs with
free plan!
Thermo Fisher Scientific Inc Financial Data Overview
Price chart is built with
Anychart
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Prev. Close
575.0279
Open
575.6379
High
581.2576
Low
569.4475
52 wk Range
385.1143-609.2749
Market Cap
215 183 M
P/E Ratio
33.0491
Shares Outstanding
376 M
Revenue
43 736 M
EPS
5.79
Dividends (Yield)
0.0029
Beta
0.906
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Thermo Fisher Scientific Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Thermo Fisher Scientific Inc data using free add-ons & libraries
Get Thermo Fisher Scientific Inc Fundamental Data
Thermo Fisher Scientific Inc Fundamental data includes:
- Net Revenue: 43 736 M
- EBITDA: 10 835 M
- Earnings Per Share: 17
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-22
- EPS/Forecast: 5.5
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Thermo Fisher Scientific Inc News
New
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director BILLERICA, Mass., November 20, 2025--(B...
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer
Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with NSCLC eligible for HER2-targeted therapy CARLSBAD, Calif., November 20, 2025--(BUSINESS WIRE...
TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner
Thermo Fisher Scientific TMO recently introduced the Thermo Scientific SureTect Beverage Spoilage Multiplex qPCR assay. The assay is an industry-first all-in-one quantitative Polymerase Chain Reaction...
OutSystems Agent Workbench Accelerates Enterprise Agentic AI Adoption
Pioneers like Thermo Fisher, Axos Bank, and Ascot Insurance have more than 5,500 AI agents in development, delivering measurable efficiency gains and optimizing workflows SINGAPORE, Nov. 20, 2025 /PR...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
